Edition:
United Kingdom

Biotage AB (BIOT.ST)

BIOT.ST on Stockholm Stock Exchange

111.40SEK
14 Jun 2019
Change (% chg)

-1.70kr (-1.50%)
Prev Close
113.10kr
Open
113.20kr
Day's High
113.40kr
Day's Low
108.60kr
Volume
133,962
Avg. Vol
141,056
52-wk High
145.00kr
52-wk Low
97.20kr

Summary

Name Age Since Current Position

Thomas Eklund

52 2018 Chairman of the Board

Torben Joergensen

67 2019 President, Chief Executive Officer, Director

Erika Soderberg Johnson

49 2012 Chief Financial Officer

Steve Jordan

65 Chief Scientific Officer

Anders Wikstrom

45 Vice President Operations

Rikke Rytter

51 2017 Vice President Global Marketing

Lars Backman

57 2007 Vice President Corporate Development

Cecilia Hallner

46 Global Human Resources Director

Love Amcoff

44 Director, Employee Representative

Mark Bradley

2019 Director

Annika Gardlund

52 2018 Director, Employee Representative

Karolina Lawitz

62 2012 Director

Peter von Ehrenheim

63 2013 Director

Biographies

Name Description

Thomas Eklund

Mr. Thomas Eklund has been Chairman of the Board of Directors of Biotage AB since April 26, 2018. He has been Director of the Company since 2006. Mr. Eklund is Independent Adviser, Consultant and Director. He holds directorships at Boule Diagnostics AB, Neoventa Medical AB, Memira AB and Rodebjer Form AB, as well as serves as Chairman of the Board of Moberg Pharma AB, Calliditas Terapeutics AB and Itrim AB. Mr. Eklund has obtained a Master of Business Administration degree from Handelshogskolan i Stockholm.

Torben Joergensen

Mr. Torben Joergensen no longer serves as President and Chief Executive Officer of Biotage AB effective as of November 6, 2019. He has held the position since April 27, 2006. He has been Director of the Company since April 24, 2019. Prior to that, he held corresponding positions at Affibody, KaroBio and the Danish diagnostic company, DAKO. Mr. Jorgensen is Chairman of the Board of Micropos Medical AB, as well as Member of the Board of Atlas Antibodies AB. He holds a Bachelor of Science degree in Economics from Copenhagen Business School.

Erika Soderberg Johnson

Ms. Erika Soderberg Johnson has been Chief Financial Officer at Biotage AB since January 2012. Prior to this, she held a corresponding position at Karo Bio. She is Member of the Board of Saab AB and Qliro Group AB. She holds Master of Business Administration degree from Handelshogskolan i Stockholm.

Steve Jordan

Mr. Steve Jordan serves as Chief Scientific Officer of Biotage AB. He has been employed at the Group for 12 years. He is Fellow of Royal Society of Chemistry.

Anders Wikstrom

Mr. Anders Wikstrom serves as Vice President Operations at Biotage AB. He has been employed at the Group for 15 years. He holds a Bachelor of Science degree.

Rikke Rytter

Ms. Rikke Rytter has been Vice President Global Marketing at Biotage AB since 2017. She holds Bachelor of Biomedical Laboratory Science.

Lars Backman

Mr. Lars Backman has been Vice President Corporate Development at Biotage AB since January 2007. Prior to joining the Company, he held the position of Senior Vice President of Corporate Development at Affibody. He has previous experience as a lawyer at the Swedish law firm Hamilton & Co, specialized in Corporate Finance and Mergers & Acquisitions, and from Venture Management at the Business Development firm Googol. He is Chairman of the Board of Chreto ApS. Mr. Backman holds Bachelor of Legal Letters degree from Stockholms universitet.

Cecilia Hallner

Ms. Cecilia Hallner serves as Global Human Resources Director at Biotage AB. She studied Human Resource Management at Uppsala universitet.

Love Amcoff

Mr. Love Amcoff serves as Director, Employee Representative at Biotage AB. He has served on the Board for six years. He holds Master of Science degree in Engineering from Kungliga Teknika Hogskolan - KTH. He is Project Manager.

Mark Bradley

Annika Gardlund

Ms. Annika Gardlund has been Director, Employee Representative at Biotage AB since 2018. She is Senior Accountant. She studied at Uppsala universitet.

Karolina Lawitz

Ms. Karolina Lawitz has been Member of the Board of Directors of Biotage AB since April 26, 2012. She is also Director at Red Glead Discovery. She has over 28 years of experience within peptide and organic synthesis with focus on heterocyclic chemistry. She holds Master of Science degree from Uppsala universitet.

Peter von Ehrenheim

Mr. Peter von Ehrenheim has been Member of the Board of Directors of Biotage AB since April 25, 2013. He is Entrepreneur. He is also Chairman of Boule Diagnostics AB, Sophion A/S, Gronsoo Sateri AB and Farjsundet Industri AB, as well as Board Member of Nanologica AB. He holds Master of Science degree in Mechanical Engineering from Kungliga Tekniska Hogskolan, KTH.